Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
Keywords: Metastatic brain tumors; Gefitinib; EGFR mutation; Lung cancer; Response rate; Survival;